Exosome Diagnostics boosts research and management team
This article was originally published in Clinica
Exosome Diagnostics (New York, New York), a company focused on commercialising its proprietary genetics-based diagnostics for oncology and endocrinology, has appointed Johan Skog as director of genetics research; Wayne Comper as chief scientific officer; and Tom Tsakeris as director of regulatory affairs. Mr Skog discovered and invented Exosome’s blood-based diagnostics and in his new role will oversee the firm’s research programme. He will continue as a post-doctoral researcher at the molecular neurogenetics unit of Massachusetts General Hospital. Mr Comper joins from AusAm Biotechnologies; he has had more than 160 articles published in peer reviewed international journals. Mr Tsakeris joins from Devices and Diagnostics Consulting Group, where he was president. He has held management roles at the US FDA, including at the Office for Device Evaluation (director) and the Center for Devices and Radiological Health.